MODERN APPROACHES TO THE TREATMENT OF BACTERIAL PNEUMONIA IN CHILDREN

Abstract

From year to year, diseases of the respiratory system occupy a leading place in their prevalence among children of various age categories. Despite the extremely wide range of antibacterial drugs on the modern pharmaceutical market, the chosen treatment strategy does not always lead to achieving the set goal. For example, community-acquired pneumonia at the moment still remains one of the main causes of death among children at an early age everywhere, which indicates the need for a detailed consideration of the drugs most often used in pediatric practice, identifying aspects of effectiveness or, conversely, their unsuccessful use [4]. When comparing two regimens of antibacterial therapy for community-acquired pneumonia in young children, there are no differences in the dynamics of clinical manifestations and length of hospital stay. Conducting rehabilitation therapy on an outpatient basis after pneumonia prevents relapses of acute respiratory diseases [1].